BYBEE CLINTON - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BYBEE CLINTON
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2026-07-01
Sale		2026-07-06
5:44 pm		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
Burow Kristina
10% Owner		16,000$2.49$39,8402,694,095
(Indirect)		View
2026-03-06
Purchase		2026-03-09
4:34 pm		Lyell Immunopharma Inc.LYELARCH Venture Fund XIII L.P.
ARCH Venture Partners XIII L.P.
ARCH Venture Partners XIII LLC
CRANDELL KEITH
NELSEN ROBERT
Burow Kristina
GILLIS STEVEN
BERNS PAUL L
BYBEE CLINTON
10% Owner		488,090$25.61$12,499,9853,247,162
(Indirect)		View
2025-10-27
Purchase		2025-10-29
7:21 pm		Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner		1,915,700$2.61$4,999,97733,847,838
(Indirect)		View
2024-04-02
Purchase		2024-04-04
4:30 pm		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
10% Owner		200,000$16$3,200,0001,181,766
(Indirect)		View
2024-02-08
Purchase		2024-02-12
5:43 pm		Sana Biotechnology Inc.SANACRANDELL KEITH
BYBEE CLINTON
Burow Kristina
GILLIS STEVEN
10% Owner		1,818,181$5.5$9,999,99622,747,272
(Indirect)		View
2023-09-19
Purchase		2023-09-20
06:16 am		Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner		1,500,000$17$25,500,0003,624,143
(Indirect)		View
2022-09-13
Purchase		2022-09-15
6:53 pm		Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner		5,000,000$1.5$7,500,00013,854,098
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2026-07-01
Exercise		2026-07-06
5:44 pm		N/A
N/A		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
Burow Kristina
10% Owner		16,000$1.032,694,095
(Indirect)		View
2026-07-01
Exercise		2026-07-06
5:44 pm		N/A
2035-06-22		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
Burow Kristina
10% Owner		16,000$02,694,095
(Indirect)		View
2024-04-02
Conversion		2024-04-04
4:30 pm		N/A
N/A		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
10% Owner		4,851,442$01,181,766
(Indirect)		View

Ownership		2024-03-27
7:56 pm		N/A
N/A		Boundless Bio Inc.BOLDCRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
GILLIS STEVEN
10% Owner		0$02,494,095
(Indirect)		View
2023-12-08
Other		2023-12-12
7:53 pm		N/A
N/A		Neumora Therapeutics Inc.NMRAARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner		1,879,654$032,424,564
(Indirect)		View
2023-09-19
Conversion		2023-09-20
06:16 am		N/A
N/A		Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner		17,424,704$03,624,143
(Indirect)		View

Ownership		2023-09-14
9:29 pm		N/A
N/A		Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Partners XII LLC
ARCH Venture Partners XII L.P.
ARCH Venture Fund XII L.P.
CRANDELL KEITH
GILLIS STEVEN
NELSEN ROBERT
BYBEE CLINTON
10% Owner		0$028,045,420
(Indirect)		View
2022-09-02
Other		2022-09-07
8:29 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		1,035,018$01,126,748
(Indirect)		View
2022-08-30
Other		2022-09-01
5:20 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		1,035,006$01,117,864
(Indirect)		View
2022-08-24
Other		2022-08-26
5:12 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		1,035,006$01,109,010
(Indirect)		View
2022-08-18
Other		2022-08-22
5:14 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		517,503$0582,653
(Indirect)		View
2022-08-12
Other		2022-08-16
9:04 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		1,552,509$01,613,232
(Indirect)		View
2022-06-08
Other		2022-06-10
9:27 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		517,503$0564,945
(Indirect)		View
2022-06-02
Other		2022-06-06
8:24 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		517,502$010,955,581
(Indirect)		View
2021-12-20
Other		2021-12-22
5:59 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		1,811,207$012,527,079
(Indirect)		View
2021-11-29
Other		2021-12-01
6:30 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		517,485$012,205,620
(Indirect)		View
2021-11-22
Other		2021-11-24
5:58 pm		N/A
N/A		Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner		517,485$012,483,411
(Indirect)		View